p38-α MAPK-IN-1

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

p38-α MAPK-IN-1 是一种 MAPK14 (p38-α) 抑制剂，在 EFC 置换试验和 HTRF 试验中 IC50 分别为 2300 nM 和 5500 nM。

p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.(In Vitro):p38-α MAPK-IN-1 is a MAPK14 (p38-α)?inhibitor(IC50 of 2300 nM, in EFC displacement assay, and 5500 nM in HTRF assay).

p38-α MAPK-IN-1 (Compound 12) is an inhibitor of MAPK14 (p38-α)>, with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay.

——

——

MAPK/ERK Signaling

p38 MAPK

Antibacterial| Antiviral| Bacterial| HSV-1| Human Endogenous Metabolite

——

——

443913-15-3

477.609

C27H35N5O3

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (209.38 mM)

Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)cc1)C(C)(C)C

——

(-20℃)

With Ice Pack

≥ 2 years